Related by context. All words. (Click for frequent words.) 76 CABG surgery 76 revascularization 71 stenting 68 coronary revascularization 68 carotid endarterectomy 68 coronary artery bypass grafting 66 repeat revascularization 66 endarterectomy 65 STEMI patients 65 Coronary Artery Bypass Graft 64 bypass grafting 64 myocardial infarction 64 reinfarction 64 MACCE 64 OPCAB 64 radical nephrectomy 64 cystectomy 64 coronary interventions 63 coronary intervention 63 multivessel disease 63 primary percutaneous coronary 63 coronary artery bypass 63 Coronary Artery Bypass Grafting 63 percutaneous coronary intervention 63 pneumonectomy 62 revascularisation 62 revascularization procedures 62 radical prostatectomy 62 carotid artery stenting 62 percutaneous coronary interventions 62 carotid stenting 62 coronary artery bypass graft 62 periprocedural 62 bivalirudin 62 reoperation 62 myocardial infarction MI 62 TAVI 62 Taxus Stent 61 patients undergoing CABG 61 percutaneous intervention 61 surgical revascularization 61 LVEF 61 eptifibatide 61 cholecystectomy 61 carotid artery stenting CAS 61 lymphadenectomy 61 paclitaxel eluting stents 61 acute coronary syndrome 60 undergoing coronary artery 60 radical cystectomy 60 liver resection 60 pump CABG 60 TACE 60 ipsilateral stroke 60 glycoprotein IIb IIIa inhibitors 60 elective PCI 60 left ventricular dysfunction 60 balloon angioplasty 60 CABG surgeries 60 hepatectomy 60 chemoradiation 60 endovascular repair 60 stenting procedures 60 DES implantation 60 severe aortic stenosis 60 underwent CABG 59 esophagectomy 59 acute coronary syndromes 59 TAVR 59 Thrombolysis 59 ICD implantation 59 nesiritide 59 perioperative mortality 59 comorbidities 59 thrombolytic therapy 59 prostatectomy 59 beta blocker therapy 59 stable angina 59 cerebrovascular events 59 revascularization procedure 59 TAXUS Express Stent 59 Operative mortality 59 nonfatal MI 59 STEMI 59 undergoing CABG 59 nephrectomy 59 CABG coronary artery 59 bypass grafts 59 everolimus eluting stents 59 fibrinolytic therapy 59 postoperative mortality 59 invasive coronary angiography 59 colectomy 59 sirolimus eluting stents 59 target vessel revascularization 58 Stenting 58 TAXUS stent 58 enoxaparin 58 occlusive disease 58 perioperative complications 58 stenoses 58 biochemical recurrence 58 NSTE ACS 58 lobectomy 58 acute STEMI 58 transfemoral 58 fibrinolysis 58 XIENCE V PROMUS Stent 58 thromboembolic events 58 antiplatelet therapy 58 NATRECOR R 58 adrenalectomy 58 ischemic cardiomyopathy 58 fondaparinux 58 ALND 58 stented 58 transurethral resection 58 reoperations 58 angioplasty stenting 58 Coronary artery bypass graft 57 VT VF 57 acute myocardial infarction AMI 57 left ventricular ejection 57 adjuvant radiotherapy 57 revascularizations 57 trabeculectomy 57 EBRT 57 UA NSTEMI 57 postoperative atrial fibrillation 57 Coronary artery bypass grafting 57 abciximab 57 nonoperative 57 partial nephrectomy 57 decompensated heart failure 57 IABP 57 TURP 57 NSTEMI 57 systolic dysfunction 57 target lesion revascularization 57 nondiabetic patients 57 saphenous vein grafts 57 ACUITY trial 57 TAXUS Stent 57 thromboembolic 57 sternotomy 57 binary restenosis 57 carotid artery stenosis 57 unfractionated heparin 57 bypass graft CABG surgery 57 angioplasty 57 LV dysfunction 57 axillary node dissection 57 PCIs 57 CYPHER Stent 57 angiography 57 tenecteplase 57 SYNTAX trial 56 patients undergoing percutaneous 56 adjuvant chemotherapy 56 coronary stenting 56 radial artery 56 antithrombotic therapy 56 cardiogenic shock 56 postoperative morbidity 56 cytoreductive surgery 56 PFO closure 56 warfarin therapy 56 thoracotomy 56 noncardiac surgery 56 carotid endarterectomy CEA 56 CABG procedures 56 tirofiban 56 myocardial infarctions 56 stenosis 56 clopidogrel 56 ventricular function 56 Acute Coronary Syndrome 56 coronary artery revascularization 56 nephron sparing surgery 56 Carotid endarterectomy 56 coronary angiography 56 cardiopulmonary bypass 56 percutaneous 56 arterial thromboembolic events 56 transcatheter aortic valve implantation 56 functional mitral regurgitation 56 noncardiac 56 mitral valve repair 56 saphenous vein graft 56 reintervention 56 colorectal liver metastases 56 recurrent VTE 56 TEVAR 56 VTE prophylaxis 56 postoperative complication 56 preserved ejection fraction 56 catheterization 56 hepatic resection 56 drug eluting stents 56 reperfusion therapy 56 CYPHER ® 56 chemoradiotherapy 56 liver transplant recipients 56 pancreatectomy 56 Percutaneous Coronary Intervention 56 EVAR 56 transthoracic 56 cryptogenic stroke 56 systemic embolism 56 intravesical therapy 56 P = .# 56 acute myocardial infarction 56 primary patency 56 conventional angiography 56 angioplasty procedures 56 total knee arthroplasty 56 nonfatal myocardial infarction 56 dual antiplatelet therapy 56 oncologic outcomes 56 CT angiography 56 ASCT 56 ST elevation myocardial 55 Stent thrombosis 55 events MACE 55 hepatic metastases 55 Acute Myocardial Infarction 55 XIENCE V demonstrated 55 stent restenosis 55 graft patency 55 Cystectomy 55 postoperative complications 55 perioperatively 55 postsurgical 55 stent placement 55 neoadjuvant therapy 55 comorbid conditions 55 thrombolysis 55 DAPT 55 myocardial ischemia 55 androgen deprivation 55 neoadjuvant 55 thrombus aspiration 55 adjuvant radiation 55 lipid lowering therapy 55 ARIXTRA 55 recanalization 55 definite stent thrombosis 55 rehospitalization 55 Radical prostatectomy 55 unstable angina UA 55 stent implantation 55 Angiographic 55 Stenting Trial CREST 55 β blockers 55 preoperative chemotherapy 55 diameter stenosis 55 Events MACE 55 salpingo oophorectomy 55 symptomatic carotid stenosis 55 cardiac surgery 55 mitral valve replacement 55 NYHA Class II 55 SLNB 55 refractory ischemia 55 TAXUS Liberte Stent 55 dronedarone 55 thromboembolism 55 arthroplasty 55 incomplete revascularization 55 Afib 55 FOLFOX4 55 perioperative morbidity 55 unresectable 55 myocardial infarction stroke 55 transplant ASCT 55 radial artery grafts 55 symptomatic VTE 55 ICD implants 55 VAD implantation 55 curative resection 55 comorbidity 55 Carotid Revascularization Endarterectomy vs. 55 chemoembolization 55 intracerebral hemorrhage 55 kidney transplant recipients 55 Fontan procedure 55 angiographic outcomes 54 GP IIb IIIa inhibitors 54 cardiopulmonary bypass CPB 54 infarction 54 anticoagulation therapy 54 MIs 54 lymph node dissection 54 laparoscopic adjustable gastric banding 54 thromboembolic complications 54 renal tumors 54 metastatic renal cell carcinoma 54 revascularized 54 antiarrhythmic drug 54 renal transplantation 54 thyroidectomy 54 Kaplan Meier analysis 54 bivalirudin alone 54 VATS lobectomy 54 SCD HeFT 54 robotic prostatectomy 54 acute ischemic stroke 54 vertebroplasty 54 conventional coronary angiography 54 CMV disease 54 tumor resection 54 Carotid stenting 54 median sternotomy 54 FFR guided 54 CYPHER ® Stent 54 intravenous diuretics 54 HSCT 54 carotid endarterectomies 54 axillary lymph node dissection 54 adjuvant therapy 54 recurrent DVT 54 uncoated stent 54 Acute Coronary Syndromes ACS 54 sirolimus stent 54 unstable angina pectoris 54 carotid surgery 54 rFVIIa 54 pulmonary artery banding 54 sirolimus eluting 54 composite endpoint 54 resynchronization therapy 54 transplantation 54 angiographically 54 recurrent ischemia 54 CYPHER R Stent 54 resections 54 recurrent GBM 54 infarctions 54 liver transplantation 54 virologic failure 54 SYNTAX 54 ticagrelor 54 carotid stenosis 54 anticoagulant therapy 54 NEVO ™ 54 Postoperative 54 cilostazol 54 VTE 54 NYHA class 54 angiographic 54 LAGB 54 paclitaxel eluting stent 54 underwent resection 54 non valvular atrial 54 Cypher Stent 54 coronary lesions 54 Nesiritide 54 nodal metastases 54 mitral regurgitation 54 ADHF 54 paroxysmal atrial fibrillation 54 alteplase 54 Angioplasty 54 reperfusion 54 balloon valvuloplasty 54 pelvic lymph node dissection 54 pacemaker implantation 54 ejection fractions 54 left ventricular systolic 54 lung transplantation 54 diastolic heart 54 pelvic lymphadenectomy 54 HF hospitalization 54 NYHA functional class 54 rebleeding 54 postoperative chemotherapy 54 onset atrial fibrillation 54 ejection fraction 54 FFR guided treatment 54 GP IIb IIIa inhibitor 54 thrombotic complications 53 platelet reactivity 53 LVSD 53 nonoperative treatment 53 TAXUS Element Stent 53 intracoronary 53 laparoscopic cholecystectomy 53 carotid revascularization 53 ECD kidneys 53 ischemic 53 aldosterone antagonists 53 paroxysmal AF 53 inhospital 53 MitraClip device 53 coronary artery bypass grafts 53 bariatric procedures 53 renal artery stenosis 53 sentinel lymph node biopsy 53 MitraClip 53 clopidogrel Plavix 53 Complication rates 53 RALP 53 everolimus eluting stent 53 coronary revascularization procedures 53 artery bypass 53 ischemia driven 53 IVUS 53 antiplatelet drugs 53 TURBT 53 pericardial effusion 53 transapical 53 carotid angioplasty 53 R0 resection 53 NMIBC 53 patency 53 radical prostatectomy RP 53 preoperative 53 aortic insufficiency 53 IV NSCLC 53 chemoradiation therapy 53 duodenal switch 53 systolic hypertension 53 infarction STEMI 53 dyssynchrony 53 coronary bypass 53 pulmonary resection 53 statin therapy 53 bivalirudin monotherapy 53 neoadjuvant chemotherapy 53 coronary artery disease 53 coronary 53 parathyroidectomy 53 meniscectomy 53 prognostic variables 53 thoracoscopic lobectomy 53 ARCOXIA 53 antihypertensive therapy 53 limb salvage 53 coronary blockages 53 cerebral aneurysms 53 risk stratification 53 Unstable Angina 53 unfractionated heparin UFH 53 bariatric procedure 53 nonischemic 53 transplantation HCT 53 palliation 53 cytoreduction 53 bronchial thermoplasty 53 PICSO ® 53 PCa 53 infarct size 53 bioprostheses 53 transradial 53 carotid artery disease 53 intracranial stenosis 53 nephrectomies 53 HbA1c levels 53 sternal wound infections 53 echocardiography 53 catheter angiography 53 TAXUS 53 angioplasties stents 53 prostate TURP 53 atrial fibrillation AF 53 donor nephrectomy 52 atrioventricular valve 52 variceal 52 atherosclerotic renal artery stenosis 52 atrial fibrillation 52 echocardiographic 52 transcatheter closure 52 aortic root replacement 52 adenoidectomy 52 rt PA 52 simvastatin ezetimibe 52 adjuvant therapies 52 total abdominal hysterectomy 52 cardiovascular hospitalization 52 aortic stenosis 52 gastrectomy 52 AF ablation 52 Abciximab 52 crossclamp 52 stent thrombosis 52 DMARD 52 p = 52 CaP 52 cerebrovascular accident 52 bifurcation lesions 52 lung resections 52 uncoated stents 52 reinterventions 52 detrusor overactivity 52 placebo dexamethasone 52 cardiovascular hospitalizations 52 Fonarow 52 coronary artery stenosis 52 graft occlusion 52 VADT 52 prostatectomies 52 resection 52 clot busting therapy 52 stent thromboses 52 percutaneous transluminal coronary angioplasty 52 undergone radical prostatectomy 52 incisional 52 renal artery stenting 52 total hip arthroplasty 52 levosimendan 52 renal insufficiency 52 renal dysfunction 52 anticoagulation 52 external beam radiotherapy 52 antireflux surgery 52 stage IIIB 52 ischemic complications 52 colon resection 52 ischemic stroke 52 polypectomy 52 postoperative AF 52 thromboprophylaxis 52 mediastinoscopy 52 candesartan 52 pulsatile flow 52 Infarction 52 inhospital mortality 52 Free Survival PFS 52 ablation procedures 52 pancreatic resection 52 Doxil ® 52 vaginal hysterectomy 52 NIHSS 52 postoperative radiotherapy 52 cirrhotic patients 52 hemorrhagic complications 52 Myocardial Infarction 52 periprocedural MI 52 RYGB 52 sirolimus eluting stent 52 pT2 52 thrombotic events 52 allogeneic stem cell 52 carotid stents 52 randomized trials 52 infarction NSTEMI 52 extracranial 52 penetrating keratoplasty 52 MADIT II 52 lung resection 52 WBRT 52 liver metastases 52 T2DM 52 XIENCE V stent 52 Y gastric bypass 52 retroperitoneal 52 infarct 52 intraoperative complications 52 postoperatively 52 Resection 52 postprocedure 52 reblockage 52 drug eluting stent implantation 52 RVOT 52 endophthalmitis 52 atherosclerotic disease 52 ICDs 52 oral anticoagulation 52 methotrexate monotherapy 52 resectable 52 CYPHER R Sirolimus eluting 52 HORIZONS AMI trial 52 STN stimulation 52 portal vein thrombosis 52 dacarbazine 52 azacitidine 52 PSADT 52 oral anticoagulant therapy 52 ticlopidine 52 randomization 52 thrombolytic agents 52 secondary efficacy endpoint 52 ruptured aneurysms 52 cardiovascular mortality 52 valvular 52 univariate analysis 52 tamponade 52 bowel resection 52 segmentectomy 52 Bivalirudin 52 coronary bypass grafting 52 de novo lesions 52 percutaneous interventions 52 intra aortic balloon 52 carotid artery blockage 52 pretest probability 52 clinically localized prostate 52 LVAS 52 arterial grafts 52 kidney transplantation 52 ICD therapy 52 lipid lowering drugs 52 decitabine 52 drug eluting stent DES 52 localized prostate cancer 52 intra arterial 52 zotarolimus eluting stent 52 ATACAND 52 CTEPH 52 NATRECOR ® 52 Zilver PTX 52 IPAH 52 eplerenone 52 pT3 52 dose atorvastatin 52 retransplantation 52 FOLFOX 52 nonobstructive CAD 51 metastatic RCC 51 cerebral infarction 51 arrhythmias 51 RF ablation 51 biventricular pacing 51 endovascular coiling 51 antibiotic prophylaxis 51 trastuzumab 51 oophorectomy 51 radical retropubic prostatectomy 51 RE LY 51 n = 51 Acute Myocardial Infarction AMI 51 asymptomatic carotid stenosis 51 dalteparin 51 refractory angina 51 angiographic restenosis 51 intravascular ultrasonography 51 cytogenetic abnormalities 51 MMSE scores 51 subtrochanteric 51 anticlotting drugs 51 coronary angioplasty 51 bypass graft surgery 51 pioglitazone 51 aortic 51 sustained ventricular tachycardia 51 macrovascular disease 51 colon resections 51 Acute Decompensated Heart Failure 51 cardiac dysfunction 51 patients undergoing noncardiac 51 severe neutropenia 51 invasive candidiasis 51 Radiofrequency Ablation RFA 51 CT angiograms 51 degenerative spondylolisthesis 51 pCR 51 undergoing coronary angiography 51 balloon dilation 51 hepatocellular carcinoma 51 vascular brachytherapy 51 advanced adenomas 51 Postoperative complications 51 STRIDE PD 51 Carotid 51 lymph node involvement 51 intermittent claudication 51 narrow QRS 51 carotid 51 TAXUS TM 51 locoregional 51 XELOX 51 endovascular procedures 51 Acute Coronary Syndromes 51 stent grafting 51 lung metastases 51 Export Aspiration Catheter 51 carotid artery stent 51 severe hypoglycemia 51 pancreatic adenocarcinoma 51 acute coronary syndromes ACS 51 resuscitated cardiac arrest 51 NNT = 51 TAXUS Liberte Long 51 drug eluting stent 51 Endoscopic 51 laparotomy 51 endovascular therapy 51 prespecified 51 D dimer 51 Randomized Evaluation 51 stent 51 PSA nadir 51 occlusions 51 carotid stent 51 INTERMACS 51 laparoscopic 51 subgroup analyzes 51 axillary dissection 51 arthrodesis 51 death reinfarction 51 5FU 51 postintervention 51 infective endocarditis 51 locoregional recurrence 51 CsA 51 lamivudine monotherapy 51 valvular disease 51 luminal diameter 51 elevated LDH 51 venous thromboembolism 51 restenosis 51 thrombolytics 51 TAXUS Express 51 fatal myocardial infarction 51 biochemical relapse 51 hypertensive patients 51 cytoreductive nephrectomy 51 warfarin 51 Coronary Artery Bypass Surgery 51 median PFS 51 MSCT 51 radiotherapy RT 51 Cardiopulmonary bypass 51 renal transplant 51 PAOD 51 CI #.#-#.# [001] 51 GnRH agonists 51 postoperative bleeding 51 tamoxifen therapy 51 endoscopically 51 post thrombotic syndrome 51 postoperative 51 sunitinib 51 silent ischemia 51 MIRP 51 postoperative delirium 51 p = #.# [003] 51 XIENCE V 51 atheroma volume 51 interventional 51 nonrandomized 51 leiomyomas 51 NIHSS score 51 fundoplication 51 Patency 51 bilateral oophorectomy 51 inguinal hernia repair 51 Minimally invasive surgery 51 advanced adenoma 51 underwent percutaneous coronary 51 oral allopurinol 51 histologically confirmed 51 invasive aspergillosis 51 adenoma 51 liver metastasis 51 vertebral fracture 51 EURIDIS 51 angiographies 51 tumor recurrence 51 venography 51 Candesartan 51 transarterial chemoembolization 51 sustained virologic response 51 intima media thickness 51 Endarterectomy 51 sinus rhythm 51 cesarean delivery 51 TAXUS p value 51 endoscopic ultrasonography 51 FOLFIRI 51 free survival PFS 51 Coronary 51 cardiac resynchronization therapy 51 thoracic aortic aneurysms 51 Percutaneous coronary intervention 51 stroke myocardial infarction 51 coronary stenosis 51 Intracranial 51 HIPEC 51 Impella 51 clopidogrel pretreatment 51 distant metastases 51 echocardiographic parameters 51 thyroid nodules 51 angioplasties 51 posttransplant 51 cardiovascular morbidity 51 Angiograms 51 FOLPI 51 valve implantation 51 clot dissolving drug 50 p = #.# [002] 50 imatinib 50 CABG Surgery 50 macrovascular events 50 evaluable 50 malperfusion 50 EuroSCORE 50 acute myocardial infarction MI 50 deep venous thrombosis 50 Major Adverse Cardiac 50 Ejection Fraction 50 noninferior 50 p = #.# [004] 50 hemoglobin A1c levels 50 uncontrolled hypertension 50 ventricular fibrillation VF 50 saphenous vein 50 myocardial reperfusion 50 electrical cardioversion 50 cerebral vasospasm 50 biliopancreatic diversion 50 aortic valve stenosis 50 noncardiovascular mortality 50 TLIF 50 transcatheter 50 OAB symptoms 50 plus glycoprotein IIb 50 Aprotinin 50 prospective nonrandomized 50 transurethral 50 catheterisation 50 ventricular dysfunction 50 embolization 50 cannulation 50 Ischemic 50 Kandzari 50 Arthroplasty 50 readmission rates 50 Readmissions 50 preoperatively 50 intravitreal injections 50 Prostatectomy 50 LMWH 50 acute decompensation 50 Androgen Deprivation Therapy 50 DCCT 50 Mitral valve repair 50 Clinical Outcomes Utilizing Revascularization 50 renal denervation 50 arteriography 50 Embolization 50 valsartan 50 ipsilateral 50 nonadherence 50 segment elevation myocardial 50 EVEREST II 50 unstable angina 50 stent insertion 50 Elitek 50 mitral stenosis 50 rivaroxaban 50 Cardiac Resynchronization Therapy 50 carboplatin paclitaxel 50 vein grafts 50 medically inoperable 50 recurrent myocardial infarction 50 Hospitalizations 50 Folfox 50 gefitinib Iressa 50 Echocardiographic 50 treated nonsurgically 50 Carotid Stenting 50 lipid lowering agents 50 cardiac tamponade 50 Patient Outcomes 50 Angioplasties 50 Percutaneous Transluminal Coronary Angioplasty 50 dose cytarabine 50 core needle biopsy 50 less invasive laparoscopic 50 antimicrobial prophylaxis 50 plus dexamethasone 50 multivariate analyzes 50 Balloon angioplasty 50 CHADS 50 distant metastasis 50 tamsulosin 50 Laparoscopic 50 IIIa inhibitor 50 coronary anatomy 50 p = NS 50 endoscopists 50 T1a 50 secondary endpoint 50 vinorelbine 50 advanced neoplasia 50 stage IIIb IV 50 proteinuria 50 EXJADE 50 Myocardial Infarction Study 50 hypertensives 50 chlorambucil 50 total knee arthroplasties 50 embolizations 50 Recurrent Stroke 50 MR imaging 50 surgical aortic valve 50 Neoadjuvant 50 postoperative hemorrhage 50 tiotropium 50 kyphoplasty 50 esophageal resection 50 postoperative pulmonary 50 eGFR 50 graft dysfunction 50 sirolimus 50 ST Segment Elevation 50 Coronary Artery 50 undergoing radical prostatectomy 50 adenotonsillectomy 50 stenting procedure 50 non squamous NSCLC 50 Cholecystectomy 50 severe sepsis 50 Subgroup analyzes 50 wedge resection 50 antithrombotic therapies 50 atrial ablation 50 underwent surgical resection 50 gout flares 50 wound dehiscence 50 Stent System 50 elective percutaneous coronary 50 microvascular complications 50 total thyroidectomy 50 endovascular interventions 50 antiplatelet agents 50 ximelagatran 50 pulmonary capillary wedge 50 urethral strictures 50 sleeve lobectomy 50 prognostic factors 50 symptomatic paroxysmal AF 50 coronary revascularisation 50 UKPDS 50 Adjuvant chemotherapy 50 colonography 50 atherectomy 50 5-FU/LV 50 vertebral fractures 50 open angle glaucoma 50 antiarrhythmic drugs 50 sentinel node biopsy 50 pulmonary artery catheter 50 peginterferon 50 adalimumab 50 venous thromboembolisms 50 transfemoral approach 50 LDLT 50 Val HeFT 50 adjuvant tamoxifen 50 neoadjuvant treatment 50 vertebral compression fractures 50 Renal dysfunction 50 candidemia 50 coronary arteriography 50 aortic regurgitation 50 radiofrequency ablation 50 metastatic malignant melanoma 50 ischemia 50 EDSS scores 50 PONV 50 TKAs 50 colorectal adenoma 50 nonsurgical treatment 50 nonischemic cardiomyopathy 50 perioperative 50 neurologic complications 50 acute cholecystitis 50 superficial femoral 50 LVH 50 femoral neck fracture 50 mm Stent 50 aldosterone antagonist 50 dose dexamethasone 50 NT proBNP 50 ventricular assist devices 50 Sirolimus Eluting Coronary Stent 50 revascularisation procedures 50 PSVT 50 bi ventricular pacing 50 metastatic malignant 50 reteplase 50 debulking surgery 50 hematologic toxicity 50 variceal bleeding 50 Median PFS 50 Hazard Ratio 50 nadolol 50 Hepatocellular Carcinoma HCC 50 eluting stent 50 mediastinal 50 intra abdominal abscess 50 venous grafts 50 AMOR IPAT 50 nondiabetics 50 prospective randomized 50 neointimal hyperplasia